Literature DB >> 12700162

Calcium-sensing receptor stimulates PTHrP release by pathways dependent on PKC, p38 MAPK, JNK, and ERK1/2 in H-500 cells.

J Tfelt-Hansen1, R J MacLeod, N Chattopadhyay, S Yano, S Quinn, X Ren, E F Terwilliger, P Schwarz, E M Brown.   

Abstract

Elevated extracellular calcium ([Ca2+]o) and other agonists potentially acting via the calcium-sensing receptor (CaR) increase parathyroid hormone-related peptide (PTHrP) release from H-500 Leydig cells. Here, we provide strong evidence for the CaR's involvement by using a dominant negative CaR that attenuates high [Ca2+]o-induced PTHrP release. This effect is likely transcriptional, because high [Ca2+]o upregulates the PTHrP transcript, an effect that is abolished by actinomycin D. Regulation of PTHrP release by the CaR involves activation of PKC as well as ERK1/2, p38 MAPK, and JNK pathways. However, we show for the first time that high [Ca2+]o-induced activation of the stress-activated protein kinase SEK1 is PKC independent, because there is an additive effect of a PKC inhibitor in combination with the JNK inhibitor on [Ca2+]o-stimulated PTHrP release. Furthermore, high [Ca2+]o, in a PKC-independent fashion, induces phosphorylation of ERK1/2, SEK1, p38 MAPK, and its downstream transcription factor ATF-2. We conclude that CaR regulation of PTHrP release in H-500 cells involves activation of PKC as well as the ERK1/2, p38 MAPK, and JNK pathways.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12700162     DOI: 10.1152/ajpendo.00489.2002

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  31 in total

1.  Sniffing calcium from the outside: an extracellular calcium sensor for synaptic vesicle recycling.

Authors:  Jennifer R Morgan
Journal:  J Physiol       Date:  2003-06-27       Impact factor: 5.182

2.  Effect of the calcium sensing receptor on rat bone marrow-derived mesenchymal stem cell proliferation through the ERK1/2 pathway.

Authors:  Zhihui Xu; Ling Yan; Yingbing Ge; Qing Zhang; Naiquan Yang; Min Zhang; Yingming Zhao; Peng Sun; Jinghong Gao; Zhengxian Tao; Zhijian Yang
Journal:  Mol Biol Rep       Date:  2012-07       Impact factor: 2.316

3.  The effects of salmon calcitonin-induced hypocalcemia on bone metabolism in ovariectomized rats.

Authors:  Rachel A Davey; Howard A Morris
Journal:  J Bone Miner Metab       Date:  2005       Impact factor: 2.626

Review 4.  International Union of Basic and Clinical Pharmacology. CVIII. Calcium-Sensing Receptor Nomenclature, Pharmacology, and Function.

Authors:  Katie Leach; Fadil M Hannan; Tracy M Josephs; Andrew N Keller; Thor C Møller; Donald T Ward; Enikö Kallay; Rebecca S Mason; Rajesh V Thakker; Daniela Riccardi; Arthur D Conigrave; Hans Bräuner-Osborne
Journal:  Pharmacol Rev       Date:  2020-07       Impact factor: 25.468

Review 5.  The calcium-sensing receptor and calcimimetics in blood pressure modulation.

Authors:  Sanela Smajilovic; Shozo Yano; Reza Jabbari; Jacob Tfelt-Hansen
Journal:  Br J Pharmacol       Date:  2011-10       Impact factor: 8.739

Review 6.  The calcium-sensing receptor in the breast.

Authors:  Joshua N Vanhouten; John J Wysolmerski
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2013-03-28       Impact factor: 4.690

7.  Inhibitory effect of hepatocyte growth factor on cardiomyocytes apoptosis is partly related to reduced calcium sensing receptor expression during a model of simulated ischemia/reperfusion.

Authors:  Ling Yan; Tie-bing Zhu; Lian-sheng Wang; Shi-yang Pan; Zheng-xian Tao; Zhijian Yang; Kejiang Cao; Jun Huang
Journal:  Mol Biol Rep       Date:  2010-11-19       Impact factor: 2.316

8.  Alterations in phosphorus, calcium and PTHrP contribute to defects in dental and dental alveolar bone formation in calcium-sensing receptor-deficient mice.

Authors:  Wen Sun; Weiwei Sun; Jingning Liu; Xichao Zhou; Yongjun Xiao; Andrew Karaplis; Martin R Pollak; Edward Brown; David Goltzman; Dengshun Miao
Journal:  Development       Date:  2010-02-11       Impact factor: 6.868

9.  Protein kinase C-beta inhibitor enzastaurin (LY317615.HCI) enhances radiation control of murine breast cancer in an orthotopic model of bone metastasis.

Authors:  Arkadiusz Z Dudek; Pawel Zwolak; Piotr Jasinski; Kaoru Terai; Nathan J Gallus; Marna E Ericson; Faris Farassati
Journal:  Invest New Drugs       Date:  2007-09-06       Impact factor: 3.850

Review 10.  Calcium-sensing receptor in cancer: good cop or bad cop?

Authors:  Bandana Chakravarti; Shailendra Kumar Dhar Dwivedi; Ambrish Mithal; Naibedya Chattopadhyay
Journal:  Endocrine       Date:  2008-11-15       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.